{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T21:13:30Z","timestamp":1782767610302,"version":"3.54.5"},"reference-count":40,"publisher":"Informa UK Limited","issue":"7","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2022,7,3]]},"DOI":"10.1080\/03007995.2022.2077579","type":"journal-article","created":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T10:29:22Z","timestamp":1652524162000},"page":"1203-1217","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and tolerability of the antispasmodic, pridinol, in patients with muscle-pain \u2013 results of primepain, a retrospective analysis of open-label real-world data provided by the German pain E-registry"],"prefix":"10.1080","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7165-9492","authenticated-orcid":false,"given":"Michael A.","family":"\u00dcberall","sequence":"first","affiliation":[{"name":"Department of Biometrics, Institute of Neurological Sciences \u2013 IFNAP, N\u00fcrnberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard H. H.","family":"M\u00fcller-Schwefe","sequence":"additional","affiliation":[{"name":"Interdisciplinary Pain and Palliative Care Center Goeppingen, Schmerz- und Palliativzentrum G\u00f6ppingen, G\u00f6ppingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Horlemann","sequence":"additional","affiliation":[{"name":"Interdisciplinary Pain Center, German Pain Association, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32154-2"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1002\/art.34347"},{"issue":"3","key":"CIT0003","first-page":"2","volume":"6","author":"von der Lippe E","year":"2021","journal-title":"J Health Monit"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.math.2005.07.001"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200102013440508"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1136\/bjsm.2010.081638"},{"key":"CIT0007","unstructured":"National Institute of Health. Low Back Pain Fact Sheet. 2019; [cited 2020 Feb 21]. Available from: https:\/\/www.ninds.nih.gov\/disorders\/patient-caregiver-education\/fact-sheets\/low-back-pain-fact-sheet."},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2019-101611"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1001\/archfami.9.10.1015"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-7-200710020-00006"},{"key":"CIT0011","unstructured":"Bundes\u00e4rztekammer (B\u00c4K), Kassen\u00e4rztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftli-chen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Nicht-spezifischer Kreuzschmerz \u2013 Langfassung, 2. Auflage. Version 1. 2017; [cited 2002 Feb 21]. Available from: https:\/\/www.leitlinien.de\/themen\/kreuzschmerz\/2-auflage."},{"issue":"457","key":"CIT0012","first-page":"640","volume":"50","author":"Schers H","year":"2000","journal-title":"Br J Gen Pract"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-018-5673-2"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.spinee.2011.03.017"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.spinee.2005.10.008"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-14-148"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.507"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10071366"},{"key":"CIT0019","unstructured":"Back-Report Switzerland. 2020. Rheumaliga Schweiz Juli 2020; [cited 2022 Feb 21]. Available from: https:\/\/www.rheumaliga.ch\/assets\/doc\/CH_Dokumente\/blog\/2020\/rueckenreport-2020\/Rueckenreport-2020.pdf."},{"key":"CIT0020","unstructured":"[cited 2022 Feb 21]. Available from: https:\/\/www.bfarm.de\/SharedDocs\/Downloads\/DE\/Arzneimittel\/Pharmakovigilanz\/PSUSAS\/s-z\/tizanidin_beschluss_cmdh.pdf?__blob=publicationFile&v=2."},{"key":"CIT0021","unstructured":"[cited 2022 Feb 21]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/press-release\/european-medicines-agency-recommends-restricting-use-tolperisone-medicines_en.pdf."},{"key":"CIT0022","unstructured":"[cited 2022 Feb 21]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/press-release\/recommendation-suspend-tetrazepam-containing-medicines-endorsed-cmdh_en.pdf."},{"key":"CIT0023","unstructured":"[cited 2022 Feb 21]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/prac-recommends-marketing-authorisation-painkiller-flupirtine-be-withdrawn_en.pdf."},{"key":"CIT0024","unstructured":"Pridinol. Myopridin\u00ae 3\u2009mg tablets (Strathmann) summary of product characteristics, last updated Aug 2019."},{"key":"CIT0025","unstructured":"Pridinol \u2013 central and peripheral muscle spasms, lumbalgia, torticollis and general muscle pain. Article in German; [cited 2022 Feb 21]. Available from: https:\/\/www.kbv.de\/media\/sp\/WirkstoffAktuell_4-21_Pridinol.pdf."},{"key":"CIT0026","unstructured":"GKV-Arzneimittelindex im Wissenschaftlichen Institut der AOK (WIdO): Deutsches Institut f\u00fcr Medizinische Dokumentation und Information (DIMDI) (Hrsg.): Anatomisch-therapeutisch-chemische Klassifikation mit Tagesdosen. Amtliche Fassung des ATC-Index mit DDD-Angaben f\u00fcr Deutschland im Jahre 2021. Berlin: DIMDI, 2021."},{"key":"CIT0027","volume-title":"[Allgemeine und spezielle pharmakologie und toxikologie]","author":"Forth W","year":"1992","edition":"6"},{"issue":"4","key":"CIT0028","first-page":"610","volume":"29","author":"Stock B","year":"1979","journal-title":"Arzneimittelforschung"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.5414\/CP203900"},{"key":"CIT0030","unstructured":"Deutsche Schmerzgesellschaft. Deutscher Schmerzfragebogen [German pain questionnaire]; [cited 2022 Feb 21]. Available from: http:\/\/www.dgss.org\/deutscher-schmerzfragebogen. (German)."},{"key":"CIT0031","unstructured":"Deutsche Schmerzgesellschaft. Handbuch zum Deutschen Schmerzfragebogen [Manual for the German pain questionnaire]; [cited 2022 Feb 21]. Available from: http:\/\/www.dgss.org\/fileadmin\/pdf\/12_DSF_Manual_2012.2.pdf. (German)."},{"key":"CIT0032","unstructured":"Kassen\u00e4rztliche Bundesvereinigung. Qualit\u00e4tssicherungsvereinbarung zur schmerztherapeutischen Versorgung chronisch schmerzkranker Patienten gem. \u00a7 135 Abs. 2 SGB V. (Qualit\u00e4tssicherungsvereinbarung Schmerztherapie); [cited 2022 Feb 21]. Available from: https:\/\/www.kbv.de\/media\/sp\/Schmerztherapie.pdf. (German)."},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(90)90068-O"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1007\/s004820050216"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1007\/s00940-016-0358-6"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1037\/1082-989X.7.1.105"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1177\/1094428106291059"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-9-38"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12020207"},{"key":"CIT0040","first-page":"796","author":"Beyeler J.","year":"1975","journal-title":"Orthop\u00e4dische Praxis"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2022.2077579","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T13:46:42Z","timestamp":1657028802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2022.2077579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,3]]}},"alternative-id":["10.1080\/03007995.2022.2077579"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2022.2077579","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-02-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}